Skip to content

Bain Capital Life Sciences Investors, LLC: ADCT position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Bain Capital Life Sciences Investors, LLC on ADCT, newest first. How the timeline and the estimate are built.

Bain Capital Life Sciences Investors, LLC reported 14,825,625 ADCT shares, 9.99%, in a 13G filed 2026-10-29.

Estimated current stake: 14,825,625 shares, 9.99% of the class

Estimated from 13G of 2026-10-29. As of 2026-10-22, 13G 0001193125-26-438199.

Shares are the reporting group's aggregate and may include entities that do not file a 13F.

  1. event date2026-10-22
    13G 14,825,625 shares
    Change vs previous stake not available

    9.99% of the class.

    13G 0001193125-26-438199 filed by Bain Capital Life Sciences Opportunities IV, L.P.
    Accepted , ingested

    A 13D/G states the aggregate of its reporting persons, which may include entities that do not file a 13F.